Trading Isn’t Getting Easier–But Options Just Did!
Options trading expert and trading champion Chuck Hughes has done it again with his guide, “Options Trading Made Easy”!

Made for new traders, this guide explains options–plus the consistent profits you could make–in easy to understand terms.

Don’t keep waiting for it to get easier–get the e-book here!
R. Sanders Williams, insider at Laboratory Co. of America

R. Sanders Williams Insider Information

Dr. R. Sanders Williams has served as a director of the Company since May 16, 2007. Dr. Williams serves currently as Senior Advisor for Science & Technology at Duke University and as President Emeritus of The J. David Gladstone Institutes, a non-profit biomedical research enterprise, holding both positions since January 1, 2018. Dr. Williams also currently is Professor of Medicine at the University of California San Francisco and Professor of Medicine at Duke University. Between February 1, 2021 and January 24, 2022 he fulfilled the role of Vice President (interim) for Research & Innovation at Duke University. Prior to these appointments he was president of The J. David Gladstone Institutes since November 2009, and he served as Chief Executive Officer of The J. David Gladstone Foundation, a non-profit organization supporting The J. David Gladstone Institutes, until December 31, 2018. Dr. Williams served Duke University between 2001 and 2010 as Dean of the School of Medicine, Senior Vice Chancellor, Senior Advisor for International Strategy, and founding Dean of the Duke-NUS Graduate Medical School Singapore. He has served previously as President of the Association of University Cardiologists, Chairman of the Research Committee of the American Heart Association, on the editorial boards of leading biomedical journals, on the Advisory Committee to the Director of the National Institutes of Health and on the board of external advisors of the National Heart, Lung and Blood Institute. Dr. Williams has served as a director of Tenaya Therapeutics, Inc. since October 2016 and has been a director of Amgen, Inc. since October 2014. Dr. Williams was a director of Bristol-Meyers Squibb Company from 2006 until 2013. Dr. Williams is a member of the National Academy of Medicine, and a Fellow of the American Association for the Advancement of Science.

What is R. Sanders Williams' net worth?

The estimated net worth of R. Sanders Williams is at least $1.33 million as of May 23rd, 2022. Dr. Williams owns 5,501 shares of Laboratory Co. of America stock worth more than $1,325,411 as of July 3rd. This net worth estimate does not reflect any other assets that Dr. Williams may own. Learn More about R. Sanders Williams' net worth.

How do I contact R. Sanders Williams?

The corporate mailing address for Dr. Williams and other Laboratory Co. of America executives is 358 South Main Street, BURLINGTON NC, 27215. Laboratory Co. of America can also be reached via phone at (336) 229-1127 and via email at [email protected] Learn More on R. Sanders Williams' contact information.

Has R. Sanders Williams been buying or selling shares of Laboratory Co. of America?

R. Sanders Williams has not been actively trading shares of Laboratory Co. of America within the last three months. Most recently, 0 shares of the stock in a transaction dated Sunday, July 3rd. Learn More on R. Sanders Williams' trading history.

Who are Laboratory Co. of America's active insiders?

Laboratory Co. of America's insider roster includes Jean-Luc Belingard (Director), Brian Caveney (EVP), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Laboratory Co. of America's active insiders.

Are insiders buying or selling shares of Laboratory Co. of America?

During the last year, Laboratory Co. of America insiders bought shares 2 times. They purchased a total of 3,542 shares worth more than $932,981.98. During the last year, insiders at the medical research company sold shares 8 times. They sold a total of 8,749 shares worth more than $2,518,006.80. The most recent insider tranaction occured on June, 7th when EVP Brian J Caveney bought 42 shares worth more than $10,171.98. Insiders at Laboratory Co. of America own 0.3 % of the company. Learn More about insider trades at Laboratory Co. of America.

Information on this page was last updated on 6/7/2022.

R. Sanders Williams Insider Trading History at Laboratory Co. of America

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/25/2022Sell572$272.98$156,144.56View SEC Filing Icon  
7/8/2020Sell1,300$173.12$225,056.006,395View SEC Filing Icon  
8/5/2019Sell500$162.91$81,455.006,886View SEC Filing Icon  
5/6/2019Sell500$162.20$81,100.007,386View SEC Filing Icon  
2/13/2019Sell1,038$147.00$152,586.008,924View SEC Filing Icon  
11/27/2018Sell350$162.14$56,749.007,886View SEC Filing Icon  
8/11/2017Sell3,100$156.88$486,328.0010,073View SEC Filing Icon  
11/2/2015Sell1,850$124.30$229,955.004,176View SEC Filing Icon  
9/5/2014Sell2,000$107.95$215,900.00View SEC Filing Icon  
See Full Table

R. Sanders Williams Buying and Selling Activity at Laboratory Co. of America

This chart shows R Sanders Williams's buying and selling at Laboratory Co. of America by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Laboratory Co. of America Company Overview

Laboratory Co. of America logo
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations. It offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.
Read More

Today's Range

Now: $240.94
Low: $235.04
High: $241.47

50 Day Range

MA: $241.29
Low: $213.86
High: $264.10

2 Week Range

Now: $240.94
Low: $212.40
High: $317.17


436,032 shs

Average Volume

918,618 shs

Market Capitalization

$22.34 billion

P/E Ratio


Dividend Yield



This Options Expert is Giving Everything Away!
Trading champion Chuck Hughes has exposed the strategies of successful traders and handing them over to new traders like you!

His guide “Options Trading Made Easy” now comes with a Trade of the Day from Chuck himself to help you develop a profitable, pro-level trading account!
Get your copy today!